Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Closed to Accrual as of 06/23/2022 to sites in the United States and Canada. Patient transfers involving US and Canadian sites must be completed by way of submitting a completed CTSU Patient Transfer Form via the Regulatory Submission Portal.

Study will remain open in Japan until it meets the targeted 45 Japanese patients.

Site staff must complete ePRO online training in Rave prior to the first patient enrollment. Additional information is available in Protocol Related Documents; to locate, use the Document Type filter and select Education and Promotion.